• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名年轻男性患者的5号染色体长臂缺失骨髓增生异常综合征

5q Deletion Myelodysplastic Syndrome in a Young Male Patient.

作者信息

Elkattawy Sherif, Ayad Sarah, El-Feki Iman, Guo Xutong, Appiah-Kubi Edmund, Talpur Afrah, Kessler William

机构信息

Internal Medicine, Rutgers-New Jersey Medical School/Trinitas Regional Medical Center, Elizabeth, USA.

Internal Medicine, St. George's University, West Indies, GRD.

出版信息

Cureus. 2021 Aug 26;13(8):e17466. doi: 10.7759/cureus.17466. eCollection 2021 Aug.

DOI:10.7759/cureus.17466
PMID:34589360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8464316/
Abstract

Myelodysplastic syndromes (MDS) are a diverse group of hematopoietic stem cell malignancies with various phenotypic variability that are categorized by abnormal differentiation of one or multiple cell lines of the bone marrow. A large part of the phenotypic heterogeneity is in part due to the wide set of genetic defects related to MDS. Though clinically, MDS is centered on diagnostic measures that do not incorporate molecular genetic data, an isolated deletion of the long arm of chromosome 5 (del(5q)) is the only subset of MDS to be identified by genetic defects. This distinctive phenotype is termed 5q-syndrome. We report a case of a 25-year-old with a past medical history of polydactyly, severe anemia, and thrombocytopenia who presented to the emergency department with a chief complaint of weakness and fatigue. Bone marrow biopsy showed myeloid neoplasm with complex genetic abnormalities, nearly 100% hyperplastic marrow with marked trilineage dysplasia, relative myeloid hyperplasia with increased abnormal eosinophilic precursors, erythroid left shift, and atypical megakaryocytes. Fluorescence in situ hybridization (FISH) panel showed deletion of 5q-. Herein, we address the clinical course and morphological characteristics as well as possible therapeutic options for 5q syndrome.

摘要

骨髓增生异常综合征(MDS)是一组异质性造血干细胞恶性肿瘤,具有多种表型变异,根据骨髓中一个或多个细胞系的异常分化进行分类。表型异质性的很大一部分部分归因于与MDS相关的广泛遗传缺陷。虽然临床上,MDS主要基于不纳入分子遗传学数据的诊断措施,但5号染色体长臂的孤立缺失(del(5q))是唯一通过遗传缺陷鉴定的MDS亚组。这种独特的表型被称为5q综合征。我们报告一例25岁患者,既往有多指畸形、严重贫血和血小板减少病史,因乏力和疲劳为主诉就诊于急诊科。骨髓活检显示髓系肿瘤伴复杂基因异常,骨髓近100%增生,有明显的三系发育异常,相对髓系增生伴异常嗜酸性前体细胞增多、红系左移和非典型巨核细胞。荧光原位杂交(FISH)检测显示5q-缺失。在此,我们阐述5q综合征的临床病程、形态学特征以及可能的治疗选择。

相似文献

1
5q Deletion Myelodysplastic Syndrome in a Young Male Patient.一名年轻男性患者的5号染色体长臂缺失骨髓增生异常综合征
Cureus. 2021 Aug 26;13(8):e17466. doi: 10.7759/cureus.17466. eCollection 2021 Aug.
2
Physician Education: Myelodysplastic Syndrome.医师教育:骨髓增生异常综合征
Oncologist. 1996;1(4):284-287.
3
Myelodysplastic Syndrome with concomitant t(5;21)(q15;q22) and del(5)(q13q33): case report and review of literature.伴有t(5;21)(q15;q22)和del(5)(q13q33)的骨髓增生异常综合征:病例报告及文献复习
Stem Cell Investig. 2016 Feb 23;3:3. doi: 10.3978/j.issn.2306-9759.2016.02.01. eCollection 2016.
4
5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).5q-综合征样特征作为一名患有不平衡全臂易位der(5;19)(p10;q10)的患者骨髓增生异常综合征的首发表现。
Int J Hematol. 2017 May;105(5):692-696. doi: 10.1007/s12185-016-2160-6. Epub 2016 Dec 2.
5
Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond.来那度胺:伴有5号染色体长臂缺失及其他情况的骨髓增生异常综合征。
Semin Hematol. 2017 Jul;54(3):159-166. doi: 10.1053/j.seminhematol.2017.06.003. Epub 2017 Jun 22.
6
Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.韩国骨髓增生异常综合征中5q缺失和5q-综合征的细胞遗传学特征;荧光原位杂交证实标记染色体为存在间质缺失的5号染色体。
Cancer Genet Cytogenet. 2010 Dec;203(2):193-202. doi: 10.1016/j.cancergencyto.2010.08.007.
7
Loss of 5q in myeloid malignancies - A gain in understanding of biological and clinical consequences.髓系恶性肿瘤中 5q 缺失——对生物学和临床后果认识的提高。
Blood Rev. 2021 Mar;46:100735. doi: 10.1016/j.blre.2020.100735. Epub 2020 Jul 23.
8
Lenalidomide: targeted anemia therapy for myelodysplastic syndromes.来那度胺:骨髓增生异常综合征的靶向性贫血治疗药物。
Cancer Control. 2006 Dec;13 Suppl:4-11. doi: 10.1177/107327480601304s02.
9
Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.伴有5号染色体长臂间质性缺失的骨髓增生异常综合征的临床管理
J Clin Oncol. 2006 Jun 1;24(16):2576-82. doi: 10.1200/JCO.2005.03.6715.
10
High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide.伴有孤立性5q缺失的低危骨髓增生异常综合征中全长cereblon mRNA的高水平与来那度胺的疗效有关。
Eur J Haematol. 2015 Jul;95(1):27-34. doi: 10.1111/ejh.12457. Epub 2014 Oct 31.

引用本文的文献

1
Rare Hematologic Malignancies and Pre-Leukemic Entities in Children and Adolescents Young Adults.儿童、青少年及青年中的罕见血液系统恶性肿瘤和白血病前期病变
Cancers (Basel). 2024 Feb 29;16(5):997. doi: 10.3390/cancers16050997.

本文引用的文献

1
Cyclosporine Broadens the Therapeutic Potential of Lenalidomide in Myeloid Malignancies.环孢素拓宽了来那度胺在髓系恶性肿瘤中的治疗潜力。
J Cell Immunol. 2020;2(5):237-244. doi: 10.33696/immunology.2.049.
2
Myelodysplastic syndromes: moving towards personalized management.骨髓增生异常综合征:走向个体化治疗。
Haematologica. 2020 Jul;105(7):1765-1779. doi: 10.3324/haematol.2020.248955. Epub 2020 May 21.
3
Molecular pathogenesis of myelodysplastic syndromes with deletion 5q.5q 缺失相关性骨髓增生异常综合征的分子发病机制。
Eur J Haematol. 2019 Mar;102(3):203-209. doi: 10.1111/ejh.13207. Epub 2019 Jan 16.
4
Myelodysplastic syndromes current treatment algorithm 2018.骨髓增生异常综合征 2018 年现行治疗算法。
Blood Cancer J. 2018 May 24;8(5):47. doi: 10.1038/s41408-018-0085-4.
5
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy.来那度胺治疗失败后接受5q缺失型骨髓增生异常综合征治疗的患者的结局
Oncotarget. 2017 Jun 14;8(47):81926-81935. doi: 10.18632/oncotarget.18477. eCollection 2017 Oct 10.
6
Erythroleukemia-historical perspectives and recent advances in diagnosis and management.红细胞白血病:历史视角与诊断和治疗的最新进展。
Blood Rev. 2018 Mar;32(2):96-105. doi: 10.1016/j.blre.2017.09.002. Epub 2017 Sep 18.
7
5q deletion myelodysplastic syndrome.5q缺失型骨髓增生异常综合征
Indian J Pathol Microbiol. 2017 Apr-Jun;60(2):301-303. doi: 10.4103/0377-4929.208396.
8
Recent Advances in the 5q- Syndrome.5q-综合征的最新进展
Mediterr J Hematol Infect Dis. 2015 May 20;7(1):e2015037. doi: 10.4084/MJHID.2015.037. eCollection 2015.
9
Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide.伴有 5q 缺失的骨髓增生异常综合征:发病机制与来那度胺的作用。
Ann Hematol. 2014 May;93(5):723-33. doi: 10.1007/s00277-014-2022-3. Epub 2014 Mar 14.
10
What lies beyond del(5q) in myelodysplastic syndrome?骨髓增生异常综合征中5号染色体长臂缺失(del(5q))之外是什么?
Haematologica. 2013 Dec;98(12):1819-21. doi: 10.3324/haematol.2013.094912.